| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.47 | 2e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |